T hrough its Priority Review mechanism, the U.S. Food and Drug Administration (FDA) recently approved 2 radiopharmaceutical products for use as diagnostic PET agents. The first, approved on May 27, was Axumin (18F-fluciclovine) injection, indicated for use in PET imaging to identify suspected sites of prostate cancer recurrence in men with elevated levels of prostate-specific antigen (PSA) foll...

Abstract Background Pancreatic neuroendocrine tumor (PNET) is a subgroup of (NET) that has unique biology and natural history. The histological classification major role in the management this pathology, but recent years Gallium 68 dotatate (68Ga-DOTA) scanning at center discussion about how these imaging technologies can modify clinical tumors their results are correlated to Ki67 index. Method...

Abstract Background After myocardial infarction (MI), inflammation and its resolution modulate the extent of damage. 68Ga-DOTATATE is a PET tracer that binds to somatostatin receptor 2 (SST2), which up-regulated in pro-inflammatory macrophages [1]. Purpose We investigated PET/MRI for quantifying post-infarct inflammation. Methods In this prospective observational cohort study, participants with...